Wednesday, 10 June 2026
Karias Health formally announced Faith, an AI care companion that has launched with their members. Faith helps patients understand what happens during medical visits and act on it immediately - serving as a single source of truth across the care journey, connecting provider instructions, member benefits, and care navigation into one integrated system that cuts through healthcare fragmentation
Talkspace (NASDAQ: TALK), a leading online behavioral healthcare provider, announced Tee, a safe, fine-tuned large language model developed by mental health experts. With HIPAA-grade privacy protections, Tee has the ability to identify potential suicide risk, homicidal/violence risk, abuse risk and seven other mental health risk entities. It is the first model of its kind providing real-time over
Revelstoke Capital Partners ("Revelstoke" or "the firm"), a Denver-based private equity firm focused on the healthcare services, healthcare technology, and health and wellness sectors, announced the launch of Revelstoke Frontier. Revelstoke Frontier was created by adding two new senior leaders to the firm focused on accelerating AI adoption and technology optimization across Revelstoke and its por
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, announced the launch of the next-generation of Lens, its pioneering agentic AI platform designed to accelerate drug development and research. This evolution seamlessly connects Tempus’ multimodal data, AI tooling and computational infrastructure to deliver actionable insights at the
Nucs AI, an AI company developing diagnostic tools and predictive imaging biomarkers for oncology and theranostics, announced a collaboration with AstraZeneca to develop AI-driven response prediction models for use in research with a PSMA-targeted radioconjugate. The collaboration focuses on metastatic prostate cancer and reflects a growing recognition that predictive imaging-based biomarkers may
HeartFocus, AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, has announced its expansion to any cart-based system with the launch of HeartFocus Link. Available now for medical schools, residency, and ultrasound training programs, HeartFocus Link addresses one of the most persistent barriers in cardiac ultrasound education and adoption: the challenge of helping he
Netsmart, an industry-leading developer of electronic health records (EHRs), augmented intelligence and automation technologies for human services and post-acute providers, announced internal engineering results from its strategic collaboration with Amazon Web Services (AWS). Through the adoption of Amazon Kiro, an agentic AI-powered development tool from AWS, Netsmart realized significa
ODYSS, a pioneer in AI-driven dietary management, announced that it had launched its Co-Creator Program for early users of its flagship product, N1. This milestone marks the transition of the world's first AI Dietary Wearable from experimental prototypes to real-world use, bringing effortless, automated dietary management to everyday life. From Manual Tracking to Effortless Insight Dietary
Biocytogen announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validat
OpenEvidence, the most widely used medical AI platform among U.S. physicians, launched Voice Mode, the first native speech-to-speech medical AI interface. With Voice Mode, OpenEvidence becomes the first multimodal medical AI offering a hands-free way for clinicians to ask questions aloud, and hear cited answers read back, on the same peer-reviewed evidence base. The feature is live in the OpenEvid
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the launch of MyLabcorp™, an AI-powered mobile app that brings together lab results, AI-enabled features and clinical guideline-based content in a secure, personalized mobile experience. The app is designed to give users additional context about their health and support more info
Incyte (Nasdaq:INCY) and Genesis Molecular AI announced a significant expansion of their strategic collaboration building and deploying state-of-the-art AI to accelerate the discovery of novel molecules for collaboration targets selected by Incyte. The expanded agreement is among the first major pharma-AI collaborations to power large-scale foundation model training with a partner's
Genedata, a Danaher company, and the leading provider of enterprise software solutions for biopharma R&D, announced the launch of Genedata Vico™, an AI–native solution to accelerate CMC processes by enabling data-driven experimentation, process monitoring, and predictive risk assessment — helping organizations strengthen regulatory readiness and reduce development delays. The
Incyte (Nasdaq:INCY) and Edison Scientific announced a strategic collaboration to employ Kosmos, Edison’s AI scientist, for Incyte’s discovery and development work. Kosmos will be embedded across the Incyte discovery and development lifecycle, enabling continuous learning from translational and clinical data, real-time synthesis of evidence and predictive models of therapeutic perform
InsideTracker, a pioneer in hyper-personalized preventive health intelligence, announced the launch of a reimagined AI platform purpose-built to make individualized, evidence-based health guidance accessible anywhere consumers engage with wellness services. A longtime leader in direct-to-consumer biomarker insights, InsideTracker is now refocusing on wellness businesses that want to deli
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, announced the launch of the Viz Pulmonary™ Suite, an integrated AI-powered solution in the Viz.ai enterprise platform, designed to help health systems streamline care delivery for pulmonary conditions. The suite brings acute and chronic pulmonary workflows together in a single solution, giving clinicians a
As organizations race to adopt agentic AI, many face a critical challenge: their most valuable knowledge remains trapped inside private documents, workflows, internal systems, and fragmented data sources. Joinable Labs announced the launch of JoinClaw, a hosted private agentic AI platform that enables users to deploy their own OpenClaw instance connected to trusted proprietary data. JoinClaw is d
Nucleus Biologics, a leading provider of custom cell culture solutions and manufacturing technologies for advanced therapies, announced the launch of NB-Lux™ AI, a next-generation digital ecosystem designed to streamline media and buffer manufacturing and management. NB-Lux™, launched in 2020, was the first cloud-based ordering portal. NB-Lux™ AI builds upon that foundation
Nuclera, the biotechnology company enabling rapid access to high-quality proteins, announced the launch of its antibody screening service to streamline the transition from antibody hit generation to lead selection. The service will support researchers seeking to identify the most promising antibody candidates to progress to costly mammalian expression and functional testing, addressing a key bottl
Rialtic, a cloud-based enterprise platform for healthcare payment accuracy, and Exponential AI, a leader in real-time healthcare AI decision intelligence, announced a definitive agreement to merge the two organizations, bringing together two of the industry’s most consequential innovators in agentic learning and claims intelligence. This strategic move creates a unified platform designed to
Waiv, formerly Owkin Dx , a Paris-based company advancing AI-based precision testing, announced that it has entered into a collaboration with Daiichi Sankyo (TSE: 4568) to drive digital disease biomarker discovery for an antibody-drug conjugate (ADC) program. With deep expertise in heterogeneous disease and multimodal data, and a global data network spanning academic institutions, hospitals,
causaLens, a London-based AI scaleup, announced the expansion of its strategic partnership with Syneos Health, a leading fully integrated biopharmaceutical solutions organization, to advance the industry’s shift toward faster, more intelligent and scalable commercialization. The companies initially partnered to execute advanced causal AI models to optimize commercial programs, pivoting
By subscribing, you agree to receive email related to content and products. You unsubscribe at any time.
Copyright 2026, AI Reporter America All rights reserved.
